Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11.

American Diabetes A. 2. Classification and diagnosis of diabetes: standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S13–27.

Article  Google Scholar 

Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–59.

Article  CAS  PubMed  Google Scholar 

Khaw K-T, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141(6):413–20.

Article  CAS  PubMed  Google Scholar 

Joshu CE, Prizment AE, Dluzniewski PJ, Menke A, Folsom AR, Coresh J, et al. Glycated hemoglobin and cancer incidence and mortality in the atherosclerosis in communities (ARIC) study, 1990–2006. Int J Cancer. 2012;131(7):1667–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study. Diabetes. 1992;41(2):202–8.

Article  CAS  PubMed  Google Scholar 

Curtin LR, Mohadjer LK, Dohrmann SM, Montaquila JM, Kruszan-Moran D, Mirel LB et al. The National Health and Nutrition Examination Survey: sample design, 1999–2006. Vital Health Stat 2. 2012(155).

Huang J, Liu Z, Ma J, Liu J, Lv M, Wang F, et al. The association between seropositivity and bone mineral density in adults. Mediators Inflamm. 2022;2022:2364666.

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Li Y, Liu Q, Li L, Feng A, Wang T, et al. Brief introduction of medical database and data mining technology in big data era. J Evid Based Med. 2020;13(1):57–69.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Huang M, Zhuang P, Jiao J, Chen X, Wang J, et al. Exposure to acrylamide and the risk of cardiovascular diseases in the National Health and Nutrition Examination Survey 2003–2006. Environ Int. 2018;117:154–63.

Article  CAS  PubMed  Google Scholar 

Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150–61.

Article  PubMed  Google Scholar 

Wu W-T, Li Y-J, Feng A-Z, Li L, Huang T, Xu A-D, et al. Data mining in clinical big data: the frequently used databases, steps, and methodological models. Mil Med Res. 2021;8(1):44.

PubMed  PubMed Central  Google Scholar 

Knol MJ, VanderWeele TJ. Recommendations for presenting analyses of effect modification and interaction. Int J Epidemiol. 2012;41(2):514–20.

Article  PubMed  PubMed Central  Google Scholar 

Bours MJL, Tutorial. A nontechnical explanation of the counterfactual definition of effect modification and interaction. J Clin Epidemiol. 2021;134:113–24.

Article  PubMed  Google Scholar 

Zhuo S, Zhang B, Zhang J, Yang M, Yu Z. Effects of dietary inflammatory index, blood lead levels, and flavonoid intake on stroke risk in older americans: a cross-sectional study. J Stroke Cerebrovasc Dis. 2023;32(11):107336.

Article  PubMed  Google Scholar 

Wang J, Liu D, Xie Y. Association between Helicobacter pylori infection and serum thyroid stimulating hormone in the National Health and Nutrition Examination Survey 1999–2000. Front Endocrinol (Lausanne). 2022;13:1018267.

Article  PubMed  Google Scholar 

Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001;322(7277):15–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luo S, Au Yeung SL, Schooling CM. Assessing the linear and non-linear association of HbA with cardiovascular disease: a Mendelian randomisation study. Diabetologia. 2021;64(11):2502–10.

Article  CAS  PubMed  Google Scholar 

Bebu I, Schade D, Braffett B, Kosiborod M, Lopes-Virella M, Soliman EZ, et al. Risk factors for first and subsequent CVD events in type 1 diabetes: the DCCT/EDIC study. Diabetes Care. 2020;43(4):867–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010;362(9):800–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossello X, Raposeiras-Roubin S, Oliva B, Sánchez-Cabo F, García-Ruíz JM, Caimari F, et al. Glycated hemoglobin and subclinical atherosclerosis in people without diabetes. J Am Coll Cardiol. 2021;77(22):2777–91.

Article  PubMed  Google Scholar 

Rentsch CT, Garfield V, Mathur R, Eastwood SV, Smeeth L, Chaturvedi N, et al. Sex-specific risks for cardiovascular disease across the glycaemic spectrum: a population-based cohort study using the UK Biobank. Lancet Reg Health Eur. 2023;32:100693.

Article  PubMed  PubMed Central  Google Scholar 

Sinning C, Makarova N, Völzke H, Schnabel RB, Ojeda F, Dörr M, et al. Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for cardiovascular risk assessment in Europe) consortium. Cardiovasc Diabetol. 2021;20(1):223.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burgess S, Malik R, Liu B, Mason AM, Georgakis MK, Dichgans M, et al. Dose-response relationship between genetically proxied average blood glucose levels and incident coronary heart disease in individuals without diabetes mellitus. Diabetologia. 2021;64(4):845–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vasudevan AR, Burns A, Fonseca VA. The effectiveness of intensive glycemic control for the prevention of vascular complications in diabetes mellitus. Treat Endocrinol. 2006;5(5):273–86.

Article  CAS  PubMed  Google Scholar 

Kovacic JC, Castellano JM, Farkouh ME, Fuster V. The relationships between cardiovascular disease and diabetes: focus on pathogenesis. Endocrinol Metab Clin North Am. 2014;43(1):41–57.

Article  PubMed  Google Scholar 

Frostegård J. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease. Clin Immunol. 2010;134(1):47–54.

Article  PubMed  Google Scholar 

Rasoul S, Ottervanger JP, Bilo HJG, Timmer JR, van ‘t Hof AWJ, Dambrink JHE et al. Glucose dysregulation in nondiabetic patients with ST-elevation myocardial infarction: acute and chronic glucose dysregulation in STEMI. Neth J Med. 2007;65(3).

Zhang X, Wu H, Fan B, Shi M, Lau ESH, Yang A, et al. The role of age on the risk relationship between prediabetes and major morbidities and mortality: analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults. Lancet Reg Health West Pac. 2023;30:100599.

PubMed  Google Scholar 

Cao Q, Xin Z, He R, Wang T, Xu M, Lu J, et al. Age-specific difference in the association between prediabetes and subclinical atherosclerosis: an analysis of a Chinese prospective cohort study. Cardiovasc Diabetol. 2022;21(1):153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575–9.

Article  PubMed  Google Scholar 

Oguntibeju OO, Odunaiya N, Oladipo B, Truter EJ. Health behaviour and quality of life of patients with type 2 diabetes attending selected hospitals in south western Nigeria. West Indian Med J. 2012;61(6):619–26.

CAS  PubMed  Google Scholar 

Yu PC, Bosnyak Z, Ceriello A. The importance of glycated haemoglobin (HbA(1c)) and postprandial glucose (PPG) control on cardiovascular outcomes in patients with type 2 diabetes. Diabetes Res Clin Pract. 2010;89(1):1–9.

Article  CAS  PubMed